About Dr Carl Feng

My goal is to understand how the host immune system combats infection while preventing immunopathology, so that lifesaving vaccines and immunotherapeutics can be developed to protect against major human pathogens.

Our research is focused on the understanding of the mechanisms mediating host resistance to respiratory pathogens, with the goal of developing novel interventions for preventing and treating respiratory infections in humans. We investigate a range of basic aspects of innate and adaptive immune responses to Mycobacterium tuberculosis and influenza virus in mice, from cytokine biology to immune regulation and tissue inflammation in the lungs. To understand the immunological basis of host defense in humans, we are also extending our studies to examine the interplay between pathogen and host signalling pathways in human cells and to identify immune correlates of protection in infected human subjects through international collaborations..

Dr. Carl Feng completed his medical education and residency training in China. After completing his PhD at the University of Sydney, Dr. Feng went to work at the National Institutes of Health (NIH) in Bethesda MD, USA. In 2012 he returned to the University of Sydney to establish his independent research program investigating immune response to respiratory pathogens.

<html />

Selected publications